ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $35,110,000 | +60.2% | 1,861,630 | 0.0% | 2.34% | +119.6% |
| Q2 2019 | $21,911,000 | -13.8% | 1,861,630 | 0.0% | 1.06% | +0.5% |
| Q1 2019 | $25,411,000 | +33.2% | 1,861,630 | 0.0% | 1.06% | +4.3% |
| Q4 2018 | $19,082,000 | -38.2% | 1,861,630 | +0.5% | 1.02% | -18.5% |
| Q3 2018 | $30,854,000 | +5.4% | 1,853,101 | 0.0% | 1.25% | +6.6% |
| Q2 2018 | $29,279,000 | +24.6% | 1,853,101 | +0.2% | 1.17% | +16.4% |
| Q1 2018 | $23,493,000 | +11.5% | 1,849,832 | +0.5% | 1.00% | +10.8% |
| Q4 2017 | $21,071,000 | +2570.6% | 1,840,246 | +2757.5% | 0.91% | +2648.5% |
| Q3 2017 | $789,000 | – | 64,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $37,365,000 | 8.14% |
| Foresite Capital Management II, LLC | 1,686,220 | $21,415,000 | 7.12% |
| Foresite Capital Management IV, LLC | 830,919 | $10,553,000 | 4.38% |
| SENZAR ASSET MANAGEMENT, LLC | 822,890 | $10,451,000 | 3.30% |
| Redmile Group, LLC | 6,505,766 | $82,623,000 | 3.19% |
| DAFNA Capital Management LLC | 396,013 | $5,029,000 | 2.45% |
| SECTORAL ASSET MANAGEMENT INC | 863,600 | $10,968,000 | 1.20% |
| Palo Alto Investors LP | 1,849,832 | $23,493,000 | 1.00% |
| Bellevue Group AG | 700,464 | $8,896,000 | 0.88% |
| Rock Springs Capital Management LP | 1,529,800 | $19,428,000 | 0.83% |